Frontiers in Genetics (Jun 2022)

The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer

  • Chengyao Chiang,
  • Chengyao Chiang,
  • Heng Yang,
  • Lizhi Zhu,
  • Chunlan Chen,
  • Cheng Chen,
  • You Zuo,
  • Duo Zheng

DOI
https://doi.org/10.3389/fgene.2022.918509
Journal volume & issue
Vol. 13

Abstract

Read online

Epigenetic modifications are essential mechanism by which to ensure cell homeostasis. One such modification is lysine methylation of nonhistone proteins by SETD7, a mono-methyltransferase containing SET domains. SETD7 methylates over 30 proteins and is thus involved in various classical pathways. As such, SETD7 has been implicated in both the basic functions of normal tissues but also in several pathologies, such as cancers. In this review, we summarize the current knowledge of SETD7 substrates, especially transcriptional-related proteins and enzymes, and their putative roles upon SETD7-mediated methylation. We focus on the role of SETD7 in cancers, and speculate on the possible points of intervention and areas for future research.

Keywords